Tomasz Tatara, Marta Dąbrowska-Bender, Aneta Duda-Zalewska, Anna Staniszewska
Safety of ombitasvir/paritaprevir/ritonavir+dasabuvir in chronic hepatitis C patients with HCV genotype 1 infection
2019-08-30
Safety of ombitasvir/paritaprevir/ritonavir+dasabuvir in chronic hepatitis C patients with HCV genotype 1 infection
54.08 kB |
30 sierpnia 2019